Lipoprotein(a) Cardiovascular Risk Threshold

Evaluates Lp(a) level as an independent cardiovascular risk factor. Lp(a) >50 mg/dL (or >125 nmol/L) constitutes an independent CV risk factor. Lp(a) is genetically determined (~90% heritability), not substantially reduced by statins, and elevated in 20–25% of the global population. Informs eligibility for PCSK9 inhibitors and emerging Lp(a)-lowering therapies.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How to Use

Enter the values for the scenario you are assessing. Evaluates Lp(a) level as an independent cardiovascular risk factor. Lp(a) >50 mg/dL (or >125 nmol/L) constitutes an independent CV risk factor. Lp(a) is genetically determined (~90% heritability), not substantially reduced by statins, and elevated in 20–25% of the global population. Informs eligibility for PCSK9 inhibitors and emerging Lp(a)-lowering therapies. Use the lp(a) cv risk result to inform your calculation.

Frequently Asked Questions